These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23839208)

  • 41. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years.
    Crawford DC; DeBerardino TM; Williams RJ
    J Bone Joint Surg Am; 2012 Jun; 94(11):979-89. PubMed ID: 22637204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical, radiological, and histological outcomes after the fibrin-matrix autologous chondrocyte implantation for chondral lesions of the knee in patients more than 50 years old: A prospective case series with minimum 2-year follow-up.
    Kim MK; Park JS; Jeon YM; Jeon YS
    J Orthop Surg (Hong Kong); 2020; 28(1):2309499019893509. PubMed ID: 31876240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint.
    Pestka JM; Bode G; Salzmann G; Südkamp NP; Niemeyer P
    Am J Sports Med; 2012 Feb; 40(2):325-31. PubMed ID: 22056348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix-induced autologous chondrocyte implantation (MACI) in the knee: clinical outcomes and challenges.
    Basad E; Wissing FR; Fehrenbach P; Rickert M; Steinmeyer J; Ishaque B
    Knee Surg Sports Traumatol Arthrosc; 2015 Dec; 23(12):3729-35. PubMed ID: 25218576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective clinical and radiologic evaluation of patellofemoral matrix-induced autologous chondrocyte implantation.
    Ebert JR; Fallon M; Smith A; Janes GC; Wood DJ
    Am J Sports Med; 2015 Jun; 43(6):1362-72. PubMed ID: 25784629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of accelerated weightbearing after matrix-associated autologous chondrocyte implantation on the femoral condyle: a prospective, randomized controlled study presenting MRI-based and clinical outcomes after 5 years.
    Wondrasch B; Risberg MA; Zak L; Marlovits S; Aldrian S
    Am J Sports Med; 2015 Jan; 43(1):146-53. PubMed ID: 25378208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autologous chondrocyte implantation for treatment of focal articular cartilage defects of the humeral head.
    Boehm E; Minkus M; Scheibel M
    J Shoulder Elbow Surg; 2020 Jan; 29(1):2-11. PubMed ID: 31547946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation for Treatment of Articular Cartilage Defect.
    Yoon KH; Park JY; Lee JY; Lee E; Lee J; Kim SG
    Am J Sports Med; 2020 Apr; 48(5):1236-1245. PubMed ID: 32125878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excellent histological results in terms of articular cartilage regeneration after spheroid-based autologous chondrocyte implantation (ACI).
    Grevenstein D; Mamilos A; Schmitt VH; Niedermair T; Wagner W; Kirkpatrick CJ; Brochhausen C
    Knee Surg Sports Traumatol Arthrosc; 2021 Feb; 29(2):417-421. PubMed ID: 32277263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Return-to-Sport Review for Current Cartilage Treatments.
    Skelley NW; Kurtenbach C; Kimber K; Piatt B; Noonan B
    J Knee Surg; 2021 Jan; 34(1):39-46. PubMed ID: 33389739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term results of autologous chondrocyte implantation in the knee for chronic chondral and osteochondral defects.
    Biant LC; Bentley G; Vijayan S; Skinner JA; Carrington RW
    Am J Sports Med; 2014 Sep; 42(9):2178-83. PubMed ID: 25002462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation: a review of 28 cases].
    Robert H; Bahuaud J; Kerdiles N; Passuti N; Capelli M; Pujol JP; Hartman D; Locker B; Hulet C; Hardy P; Coudane H; Rochverger A; Francheschi JP;
    Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):701-9. PubMed ID: 18065881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors predictive of outcome 5 years after matrix-induced autologous chondrocyte implantation in the tibiofemoral joint.
    Ebert JR; Smith A; Edwards PK; Hambly K; Wood DJ; Ackland TR
    Am J Sports Med; 2013 Jun; 41(6):1245-54. PubMed ID: 23618699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revision surgery after third generation autologous chondrocyte implantation in the knee.
    Niethammer TR; Valentin S; Ficklscherer A; Gülecyüz MF; Pietschmann MF; Müller PE
    Int Orthop; 2015 Aug; 39(8):1615-22. PubMed ID: 25947902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sporting Activity Is Reduced 11 Years After First-Generation Autologous Chondrocyte Implantation in the Knee Joint.
    Erdle B; Herrmann S; Porichis S; Uhl M; Ghanem N; Schmal H; Suedkamp N; Niemeyer P; Salzmann GM
    Am J Sports Med; 2017 Oct; 45(12):2762-2773. PubMed ID: 28787185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective Long-term Follow-up of Autologous Chondrocyte Implantation With Periosteum Versus Matrix-Associated Autologous Chondrocyte Implantation: A Randomized Clinical Trial.
    Barié A; Kruck P; Sorbi R; Rehnitz C; Oberle D; Walker T; Zeifang F; Moradi B
    Am J Sports Med; 2020 Jul; 48(9):2230-2241. PubMed ID: 32667270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years.
    Niemeyer P; Laute V; Zinser W; John T; Becher C; Diehl P; Kolombe T; Fay J; Siebold R; Fickert S
    Knee Surg Sports Traumatol Arthrosc; 2020 Apr; 28(4):1130-1143. PubMed ID: 31897548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical outcomes after cell-seeded autologous chondrocyte implantation of the knee: when can success or failure be predicted?
    Pestka JM; Bode G; Salzmann G; Steinwachs M; Schmal H; Südkamp NP; Niemeyer P
    Am J Sports Med; 2014 Jan; 42(1):208-15. PubMed ID: 24166804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autologous chondrocyte implantation for chondral defects of the knee: indications and technique.
    King PJ; Bryant T; Minas T
    J Knee Surg; 2002; 15(3):177-84. PubMed ID: 12152980
    [No Abstract]   [Full Text] [Related]  

  • 60. A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee.
    Schneider U; Rackwitz L; Andereya S; Siebenlist S; Fensky F; Reichert J; Löer I; Barthel T; Rudert M; Nöth U
    Am J Sports Med; 2011 Dec; 39(12):2558-65. PubMed ID: 21984690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.